Digital Therapeutics for Menopause in the Workplace

工作场所更年期的数字治疗

• 批准号: 10016298
• 金额: $ 6.36万
• 依托单位: SYRONA LIMITED
• 依托单位国家: 英国
• 项目类别: Small Business Research Initiative
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10016298
• 关键词: Digital; Therapeutics; Menopause; Workplace

Menopause is a natural process of life, resulting in up to 34 recognised symptoms. The severity and frequency of these symptoms can be debilitating and negatively impact those experiencing menopause at work. Given that 15.5 million women are currently in employment, measures need to be put in place to understand better the unique needs of those experiencing menopause in the workplace. Currently there are only 29 NHS menopause clinics in the U.K (average waiting times-6months).Thus, SORA has the commercial potential to support 72% of women in work who say they feel unsupported, reducing absenteeism and long term sick leaves taken.SORA is topical given 77% of NHS staff are female, with an average age of 43.We propose an inquiry to understand the experiences of those in the workforce going through menopause and create patient-centred digital therapeutics (DTx) solutions to support them.

更年期是一个自然的生命过程，导致多达34个公认的症状。这些症状的严重程度和频率可能会使人衰弱，并对那些在工作中经历更年期的人产生负面影响。鉴于目前有1 550万妇女就业，需要采取措施，更好地了解工作场所更年期妇女的独特需求。目前，英国只有29家NHS更年期诊所（平均等待时间-6个月）。因此，索拉计划具有支持72%的工作妇女的商业潜力，这些妇女说她们感到没有得到支持，从而减少缺勤和长期病假。索拉计划具有现实意义，因为国民保健服务77%的工作人员是女性，我们提出了一项调查，以了解那些正在经历更年期的劳动力的经历，并创建以患者为中心的数字治疗（DTx）解决方案来支持他们。